First human trial of AKB-9090 in healthy adults
This study is testing a new medication called AKB-9090 for the first time in people. It will help find out how the drug works in the body and how safe it is. The study is looking for healthy volunteers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be in good general health with no major medical issues.
- Your body mass index (weight relative to height) must be between 18.5 and 32.
- You cannot use tobacco, caffeine, or alcohol during the study.
- You must not have had cancer (except minor skin cancers or fully treated cervical/colon cancers) in the last 2 years.
- You cannot have certain infections like active hepatitis B or C.
- You must be willing to stay at the study site and follow all study rules.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called RO7806881 in healthy volunteers to see if it is safe, what dose is best, and how the body handles it. It is an early study that helps researchers decide if the drug should be tested in people with a disease.
This trial tests a new medicine called AB102 in healthy people to see if it is safe and how the body processes it. It may help researchers understand the right dose for future studies.
This trial tests a new medicine called AK139 in healthy people to see how safe it is and how the body processes it. It is for healthy adults aged 18 to 55.
This trial tests a new drug called AK0610 in healthy volunteers aged 18 to 50. It helps researchers understand how the drug works in the body and whether it is safe before moving to larger studies.
This study tests the safety and how the body processes a new drug called AK0406 in healthy adults. If you are generally healthy and match the age and weight requirements, you may be able to help researchers understand if the drug is safe before it is tested in people with a medical condition.
This trial tests the safety of a new drug called KT-579 in healthy adults. It is the first time this drug is being given to humans. The study will help doctors understand how the drug works in the body and if it is safe.
Hear when a new Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.